Albendazole Dosing for Cystic Echinococcosis (Hydatid Cysts)
Albendazole is recommended at 10–15 mg/kg/day PO in two divided doses (maximum 400 mg PO twice daily) with a fat-rich meal to improve bioavailability. [1] Treatment should be given continuously (without the older monthly interruption strategy). [1] Current recommendations support continuous treatment for 3–6 months, with duration individualized to cyst stage and size. [1]
Weight-Based Dosing Regimen
- Dose: 10–15 mg/kg/day PO. [1]
- Division: administered in 2 divided doses per day. [1]
- Maximum daily dose: up to 400 mg twice daily (800 mg/day). [1]
- Administration: given with a fat-rich meal to increase bioavailability. [1]
Treatment Duration in Adults and Children
- General medical therapy (continuous albendazole alone): 3–6 months. [1]
- Cyst fluid spillage (suspected or ascertained): minimum 3 months, usually 6–12 months after the intervention, based on clinical assessment. [1]
Duration Around Interventions (Contextual Refinement)
- With percutaneous procedures (PAIR): standard practice is 1–7 days before the procedure and 1–3 months after the procedure at 10–15 mg/kg/day. [1]
- With surgery: standard practice is 1–7 days before the procedure and 1–3 months after the procedure at 10–15 mg/kg/day. [1]
Regulatory/Label-Based Cyclic Regimen (Older/Common Package Insert Approach)
Some drug labeling describes a cyclic regimen of 28-day treatment cycles separated by 14 drug-free days, for a total of 3 cycles. [2]
Key Monitoring Considerations
Albendazole requires monitoring for hepatotoxicity and hematologic toxicity based on liver enzymes and blood cell counts during therapy. [1]
Target Populations and Applicability
The albendazole dosing approach is stated for adults and children because the regimen is weight-based and uses the same mg/kg/day framework. [1]